Corteva delivered Q4 2025 revenue of $3.9 billion with strong Seed profitability and resilient Crop Protection volumes, but results were weighed down by seasonal volume shifts and cost pressures, resulting in a GAAP net loss.

Corteva delivered strong Q3 2025 sales growth in both Seed and Crop Protection segments, driven by volume increases and demand for new products. Despite the top-line growth, the company reported a net loss due to pricing pressures and higher operating costs. However, performance exceeded expectations, prompting an upward revision of full-year guidance.

Corteva delivered solid second quarter results with 6% revenue growth, strong earnings, and robust segment performance, driven by volume gains in both Seed and Crop Protection.

Corteva reported higher operating EPS and net income in Q1 2025 driven by robust demand for its differentiated technology and operational efficiencies, despite a slight decline in GAAP revenue.

Corteva's fourth quarter 2024 results showed significant growth, with net sales increasing 7% to $4.0 billion and organic sales up 13%. Operating EBITDA rose 36% to $525 million, and operating EPS increased 113% to $0.32. This performance was driven by strong volume gains in both Crop Protection and Seed, particularly in Brazil.

Corteva's third quarter results were impacted by reduced planted area and market dynamics in Latin America, as well as competitive pricing environment in Crop Protection. Net sales decreased by 10% and the company reported a GAAP loss of $519 million. Crop Protection volume increased due to demand in Latin America and North America, while Seed volume declined due to reduced corn planted area in Argentina. The company updated its full-year 2024 guidance.

Corteva reported a 1% increase in net sales for the second quarter of 2024, with organic sales up by 2%. The Seed business showed strength, while the Crop Protection segment faced challenges due to destocking and competitive pressures. The company has updated its full-year guidance to reflect current market dynamics.

Corteva reported a decrease in net sales by 8% and a decrease in EPS to $0.53. Seed sales increased by 2%, while Crop Protection sales decreased by 20%. The company reaffirmed its full-year 2024 guidance.

Corteva's fourth-quarter 2023 results showed a decrease in net sales and a GAAP loss, but operating EBITDA improved. The decline was attributed to volume decreases, especially in Latin America, while price increases partially offset the negative impact. The company provided 2024 guidance, expecting net sales and operating EBITDA growth.

Corteva reported a 7% decrease in net sales for the third quarter of 2023, with a GAAP loss from continuing operations of $315 million and a non-GAAP operating EPS of $(0.23). The sales decline was attributed to lower volumes, particularly in the Crop Protection segment, although price increases partially mitigated the impact. Management has affirmed the full-year net sales and earnings guidance.

Corteva reported a decrease in net sales by 3% for the second quarter of 2023. While the Seed segment showed strong performance, it was offset by headwinds in the Crop Protection segment. The company has updated its full-year net sales and earnings guidance.

Corteva's first quarter 2023 results showed a 6% increase in net sales compared to the prior year, with gains in both segments. GAAP EPS was $0.84, while non-GAAP operating EPS was $1.16. The company raised its full-year guidance, including the impact of biologicals acquisitions.

Corteva's Q4 2022 results showed a 10% increase in net sales, driven by price increases, but the company reported a GAAP loss from continuing operations of $41 million. Operating EBITDA increased by 41% compared to the prior year. The company provided full-year 2023 guidance, expecting net sales in the range of $18.1 billion to $18.4 billion.

Corteva's third quarter results showed a 17% increase in net sales and a significant improvement in Operating EBITDA, driven by focused global execution and strong customer demand. The company is progressing with portfolio actions, including the acquisition of Symborg and the decision to exit commodity glyphosate products. Looking ahead to 2023, the company expects a dynamic operating environment with macroeconomic pressures, but remains focused on executing its strategic plan and serving customers.

Corteva reported an 11% increase in net sales and an 18% increase in Operating EBITDA compared to the same quarter last year. The growth was driven by strong demand for crop protection products and price increases. Management also raised full year 2022 net sales and earnings guidance.

Corteva reported a solid start to 2022 with double-digit sales and Operating EBITDA growth in the first quarter. The company's strategic initiatives to accelerate performance and the business realignment are expected to enhance simplicity and speed of business. Healthy market fundamentals are expected to continue given record crop prices, strong farm income levels and demand for food globally.

Corteva's Q4 2021 results showed an 8% increase in net sales and a 57% increase in GAAP EPS compared to Q4 2020. The company's performance was driven by double-digit gains in Latin America and strong demand for new technologies.

Corteva reported a strong third quarter with net sales increasing by 27% and organic sales rising by 24%. Volume gains and strong price execution drove Operating EBITDA improvement of 72%. The company has increased its net sales and Operating EPS guidance for the full year.

Corteva reported an 8% increase in net sales and a 36% increase in EPS for the second quarter of 2021. The company's performance was driven by strong demand for its innovative products, its ability to price for value, and its focus on execution.

Corteva reported strong first quarter results with net sales of $4.18 billion, a 6% increase compared to the prior year. The company's GAAP EPS was $0.81, up 125% from Q1 2020, and non-GAAP Operating EPS was $0.79, a 34% increase. Operating EBITDA increased by 14% to $904 million. Management increased full year 2021 net sales guidance to a range of $14.6 to $14.8 billion and affirmed full year 2021 Operating EBITDA guidance in the range of $2.4 billion to $2.5 billion.

Corteva's Q4 2020 results showed an 8% increase in net sales and a significant 336% increase in GAAP income from continuing operations after tax. The company's performance was driven by the adoption of new technologies in Seed and Crop Protection, as well as cost and productivity actions, which offset negative impacts from currency and divestitures.

Corteva's third-quarter results showed a mixed performance with a 3% decrease in net sales, totaling $1.86 billion, but a 9% increase in organic sales. The company experienced a GAAP loss of $(390) million, or $(0.52) per share. Crop Protection net sales grew by 9%, while Seed net sales decreased by 23%. The company is affirming its full-year guidance for 2020.

Corteva reported a 6% increase in net sales and a $174 million improvement in operating EBITDA for the fourth quarter of 2019. Volume gains were driven by Crop Protection in North America and sales of new products in Latin America and EMEA. The company achieved approximately $50 million in merger-related synergies during the quarter.